TriSalus Life Sciences (TLSI) Receivables (2022 - 2025)
Historic Receivables for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $5.0 million.
- TriSalus Life Sciences' Receivables rose 179.15% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year increase of 179.15%. This contributed to the annual value of $5.1 million for FY2024, which is 4130.56% up from last year.
- According to the latest figures from Q3 2025, TriSalus Life Sciences' Receivables is $5.0 million, which was up 179.15% from $5.6 million recorded in Q2 2025.
- TriSalus Life Sciences' 5-year Receivables high stood at $5.6 million for Q2 2025, and its period low was $1.6 million during Q4 2022.
- In the last 4 years, TriSalus Life Sciences' Receivables had a median value of $4.8 million in 2024 and averaged $4.3 million.
- Its Receivables has fluctuated over the past 5 years, first surged by 13121.39% in 2023, then soared by 179.15% in 2025.
- TriSalus Life Sciences' Receivables (Quarter) stood at $1.6 million in 2022, then skyrocketed by 131.21% to $3.6 million in 2023, then skyrocketed by 41.31% to $5.1 million in 2024, then dropped by 1.71% to $5.0 million in 2025.
- Its Receivables was $5.0 million in Q3 2025, compared to $5.6 million in Q2 2025 and $5.5 million in Q1 2025.